Assessing the impact of afforestation as a natural climate solution in the Canadian boreal von du Toit, Francois, Coops, Nicholas C, Mulverhill, Christopher, Toomey, Aoife

Volltext

Numerical simulation of seismic waves using a discrete particle scheme von Toomey, Aoife, Bean, Christopher J.

Volltext

Fracture properties from seismic data - a numerical investigation von Toomey, Aoife, Bean, Christopher J., Scotti, Oona

Volltext

Fracture properties from seismic data: a numerical investigation von TOOMEY, Aoife, BEAN, Christopher J, SCOTTI, Oona

Volltext

Preclinical evaluation of the CDK4/6 inhibitor palbociclib in combination with a PI3K or MEK inhibitor in colorectal cancer von Lee, Cha Len, Cremona, Mattia, Farrelly, Angela, Workman, Julie A., Kennedy, Sean, Aslam, Razia, Carr, Aoife, Madden, Stephen, O'Neill, Brian, Hennessy, Bryan T., Toomey, Sinead

Volltext

Demystifying Open Science in health psychology and behavioral medicine: a practical guide to Registered Reports and Data Notes von Norris, Emma, O'Mahony, Aoife, Coyne, Rory, Varol, Tugce, Green, James A., Reynolds, James, Toomey, Elaine

Volltext

Targeting the PI3K and MAPK pathways to improve response to HER2-targeted therapies in HER2-positive gastric cancer von Mezynski, M Janusz, Farrelly, Angela M, Cremona, Mattia, Carr, Aoife, Morgan, Clare, Workman, Julie, Armstrong, Paul, McAuley, Jennifer, Madden, Stephen, Fay, Joanna, Sheehan, Katherine M, Kay, Elaine W, Holohan, Ciara, Elamin, Yasir, Rafee, Shereen, Morris, Patrick G, Breathnach, Oscar, Grogan, Liam, Hennessy, Bryan T, Toomey, Sinead

Volltext

Protein Tyrosine Phosphatase Non-Receptor 11 ( PTPN11 /Shp2) as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC) von Richards, Cathy E, Elamin, Yasir Y, Carr, Aoife, Gately, Kathy, Rafee, Shereen, Cremona, Mattia, Hanrahan, Emer, Smyth, Robert, Ryan, Daniel, Morgan, Ross K, Kennedy, Susan, Hudson, Lance, Fay, Joanna, O'Byrne, Kenneth, Hennessy, Bryan T, Toomey, Sinead

Volltext

Germline single nucleotide polymorphisms in ERBB3 and BARD1 genes result in a worse relapse free survival response for HER2-positive breast cancer patients treated with adjuvant ba... von Coté, Damien, Eustace, Alex, Toomey, Sinead, Cremona, Mattia, Milewska, Malgorzata, Furney, Simon, Carr, Aoife, Fay, Joanna, Kay, Elaine, Kennedy, Susan, Crown, John, Hennessy, Bryan, Madden, Stephen

Volltext

Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies von Shannon, Aoife M, Bouchier-Hayes, David J, Condron, Claire M, Toomey, Deirdre

Volltext

Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted ther... von Toomey, Sinead, Eustace, Alexander J, Fay, Joanna, Sheehan, Katherine M, Carr, Aoife, Milewska, Malgorzata, Madden, Stephen F, Teiserskiene, Ausra, Kay, Elaine W, O'Donovan, Norma, Gallagher, William, Grogan, Liam, Breathnach, Oscar, Walshe, Janice, Kelly, Catherine, Moulton, Brian, Kennedy, M John, Gullo, Guiseppe, Hill, Arnold D, Power, Colm, Duke, Deirdre, Hambly, Niamh, Crown, John, Hennessy, Bryan T

Volltext

Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples von Toomey, Sinead, Carr, Aoife, Mezynski, Mateusz Janusz, Elamin, Yasir, Rafee, Shereen, Cremona, Mattia, Morgan, Clare, Madden, Stephen, Abdul-Jalil, Khairun I, Gately, Kathy, Farrelly, Angela, Kay, Elaine W, Kennedy, Susan, O'Byrne, Kenneth, Grogan, Liam, Breathnach, Oscar, Morris, Patrick G, Eustace, Alexander J, Fay, Joanna, Cummins, Robert, O'Grady, Anthony, Kalachand, Roshni, O'Donovan, Norma, Kelleher, Fergal, O'Reilly, Aine, Doherty, Mark, Crown, John, Hennessy, Bryan T

Volltext

Protein Tyrosine Phosphatase Non-Receptor 11 von Richards, Cathy E, Elamin, Yasir Y, Carr, Aoife, Gately, Kathy, Rafee, Shereen, Cremona, Mattia, Hanrahan, Emer, Smyth, Robert, Ryan, Daniel, Morgan, Ross K, Kennedy, Susan, Hudson, Lance, Fay, Joanna, O’Byrne, Kenneth, Hennessy, Bryan T, Toomey, Sinead

Volltext

Development of a personalized therapeutic strategy for ERBB-gene-mutated cancers von Milewska, Malgorzata, Cremona, Mattia, Morgan, Clare, O’Shea, John, Carr, Aoife, Vellanki, Sri HariKrishna, Hopkins, Ann M., Toomey, Sinead, Madden, Stephen F., Hennessy, Bryan T., Eustace, Alex J.

Volltext

Abstract P1-19-24: A phase Ib trial of copanlisib in combination with trastuzumab in pretreated recurrent or metastatic HER2-positive breast cancer “PantHER” von Keegan, Niamh M, Furney, Simon, Walshe, Janice, Gullo, Giuseppe, Kennedy, John, Bulger, Kyran, McCaffrey, John, Kelly, Catherine M, Egan, Keith, O'Donovan, P, Hernando, Andres, Teiserskiene, Ausra, Parker, Imelda, Farrelly, Angela M, Carr, Aoife, Calzaferri, Giulio, McDermott, Ray, Keane, Maccon M, Grogan, Liam, Breathnach, Oscar S, Morris, Patrick G, Toomey, Sinead, Hennessy, Bryan T

Volltext

Clonal evolution in locally advanced rectal cancers in response to neoadjuvant chemoradiotherapy von Toomey, Sinead, Carr, Aoife, Gunther, Jillian Rebecca, Fay, Joanna, O'Grady, Anthony, Weksberg, David, Piraino, Scott W, Kay, Elaine, O'Neill, Brian, Krishnan, Sunil, Furney, Simon J, Hennessy, Bryan

Volltext

Developing an open educational resource for open research: Protocol for the PaPOR TRAIL project von Egan, Sophia, Tobin, Mary, Palmer, Brendan, Coffey, Aoife, Dahly, Darren, Houghton, Catherine, Ó Carragáin, Eoghan, Toomey, Elaine, Dockray, Samantha, Matvienko-Sikar, Karen

Volltext

Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer von Kalachand, Roshni D., O’Riain, Ciaran, Toomey, Sinead, Carr, Aoife, Timms, Kirsten M., O’Toole, Sharon, Madden, Stephen, Bates, Mark, O’Leary, John J., Gleeson, Noreen, O’Donnell, Dearbhaile, Grogan, Liam, Breathnach, Oscar, Farrelly, Angela, Stordal, Britta, Hennessy, Bryan T.

Volltext

Abstract B25: PI3K targeted inhibition in NSCLC: An in vitro evaluation and correlation of mutation status to activated PI3K pathway signaling in NSCLC patients von Heavey, Susan, Toomey, Sinead, Carr, Aoife, Cuffe, Sinead, Finn, Stephen, Hennessy, Bryan, Crown, John, Barr, Martin, O'Byrne, Kenneth, Gately, Kathy

Volltext

A preclinical evaluation of the MEK inhibitor refametinib in HER2-positive breast cancer cell lines including those with acquired resistance to trastuzumab or lapatinib von O'Shea, John, Cremona, Mattia, Morgan, Clare, Milewska, Malgorzata, Holmes, Frankie, Espina, Virginia, Liotta, Lance, O'Shaughnessy, Joyce, Toomey, Sinead, Madden, Stephen F, Carr, Aoife, Elster, Naomi, Hennessy, Bryan T, Eustace, Alex J

Volltext